That is 0 articles you have read today.
The Aporia is free and carries no advertising, so readers are the only
thing paying for it. If you are getting this much out of it, a small
donation is what keeps it independent.
Daily limit reached
You have read 0 articles today.
That is more than the 15 a day The Aporia gives away,
and well past what it can carry on nothing. Your allowance resets at
midnight.
There is no advertising here and nothing about you is sold, so readers
are the only thing paying for it. If the site is worth this much of
your day, it is worth a few dollars.
Everything else stays open: the
maps, the
directory and
search do
not count against this, and neither does re-opening something you have
already read today.
Abbott Laboratories has agreed to pay $385 million to settle legal claims related to a 2022 baby formula shortage caused by a recall at its Sturgis, Michigan plant. The Justice Department initiated a lawsuit amid concerns over bacterial contamination, leading to a nationwide recall of Abbott's major infant formula brands like Similac and exacerbating existing supply chain issues. While the settlement does not admit fault, Abbott emphasized that no unopened, distributed products tested positive for harmful bacteria. The company had shut down then reopened the plant following an FDA investigation.
Written by the local model on 2026-09-15,
using this article's own text rather than the other coverage of the
same event.
Claims extracted
8
claim-shaped sentences
Uncertain
12%
1 of 8 hedged
Leaning
Centre
of the writing, not the subject
Correction & hedging signals
59.2
corrections and hedging in what we collected;
not a measure of accuracy
Outlets on this story
unclustered
not grouped into a story yet
Narrative spread
1
articles carrying this framing
Why this leaning score
The article's own words the score was based on. Each is quoted
verbatim and was checked against the article text before being
stored, so you can find it in the original.
Leaning score -0.15 for article 10332 (high confidence, 1 verified quote) · logged 2026-09-15
Abbott Laboratories will pay $385 million to resolve legal claims arising from a contamination inquiry at its baby formula manufacturing plant in Sturgis, Michigan, the nation's largest, which triggered severe supply shortages in 2022.
uncertain
which → pay → 2022
Concerns regarding the facility resulted in a lawsuit by the Justice Department alongside a sweeping recall of powdered formula products.
Affecting multiple major lines such as Similac, the recall further strained inventory already burdened by supply chain bottlenecks and stockpiling during COVID-19 shutdowns.
asserted
recall → regard → shutdowns
The settlement covers litigation initiated by specific relators as well as the Attorneys General of multiple states, though Abbott stated the resolution contains no finding of fault or liability.
asserted
resolution → cover → fault
Abbott stated on Monday that regulatory tests on unopened formula retrieved from homes of infants investigated during the 2022 recall were negative for Cronobacter sakazakii, a bacterium that can cause illness in infants.
asserted
that → state → infants
Furthermore, the company emphasized that no unopened, distributed Abbott formula products have ever tested positive for the bacteria.
asserted
products → emphasize → bacteria
A criminal investigation into the matter conducted by the Justice Department under President Donald Trump has since been closed.
asserted
investigation → conduct → Trump
To address the shortage, the Biden administration relaxed import rules for foreign manufacturers, airlifted formula from Europe, and invoked federal emergency regulations to prioritize U.S. production.
asserted
administration → address → production
Abbott closed the Sturgis facility in February 2022 following the start of an investigation by the Food and Drug Administration, before reopening it in June of that year.
asserted
Abbott → close → year
The Aporia
